TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Immunovia AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
142
|
103
|
83 |
| Financial expenses |
1,735
|
1,636
|
371 |
| Earnings before taxes |
-27,887
|
-15,105
|
-15,251 |
| EBITDA |
-13,946
|
-14,938
|
-14,429 |
| Total assets |
8,893
|
27,011
|
48,285 |
| Current assets |
7,256
|
10,389
|
29,051 |
| Current liabilities |
2,695
|
2,164
|
3,202 |
| Equity capital |
6,037
|
21,908
|
42,428 |
| - share capital |
204
|
102
|
111 |
| Employees (average) |
36
|
64
|
66 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
67.9%
|
81.1%
|
87.9% |
| Turnover per employee |
4
|
2
|
1 |
| Profit as a percentage of turnover |
-19638.7%
|
-14665.0%
|
-18374.7% |
| Return on assets (ROA) |
-294.1%
|
-49.9%
|
-30.8% |
| Current ratio |
269.2%
|
480.1%
|
907.3% |
| Return on equity (ROE) |
-461.9%
|
-68.9%
|
-35.9% |
| Change turnover |
39
|
27
|
47 |
| Change turnover % |
38%
|
36%
|
133% |
| Chg. No. of employees |
-28
|
-2
|
3 |
| Chg. No. of employees % |
-44%
|
-3%
|
5% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.